Structure |
Chemical Name |
CAS |
MF |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](../cas/20200401/gif/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
![L-Milnacipran Carbamoyl-beta-D-Glucuronide](../cas/20211123/gif/1446438-98-7.gif) |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](../cas/20200401/gif/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
![Elagolix Sodium impurity5](../) |
Elagolix Sodium impurity5 |
|
|
![Tadalafil Impurity 46](../) |
Tadalafil Impurity 46 |
|
|
![(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol](../cas/20200401/gif/cb85519895.gif) |
(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
![cefdinir](../) |
cefdinir |
|
|
![ACICLOVIR, Impurity J](../) |
ACICLOVIR, Impurity J |
|
|
![1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl-](../cas/20200401/gif/91639-43-9.gif) |
1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl- |
91639-43-9 |
C12H15N |
![Salbutamol impurity 42](../cas/20200401/gif/18910-69-5.gif) |
Salbutamol impurity 42 |
18910-69-5 |
C14H23NO3 |
![(E)-8-(3,4-dimethoxystyryl)](../) |
(E)-8-(3,4-dimethoxystyryl) |
|
|
![tert-butyl (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoate](../) |
tert-butyl (3R,5R)-7-((3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanamido)-3,5-dihydroxyheptanoate |
|
|
![(+)-Mediresinol Di-O-β-D-glucopyranoside](../cas/20210111/gif/88142-63-6.gif) |
(+)-Mediresinol Di-O-β-D-glucopyranoside |
88142-63-6 |
C33H44O17 |
![(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol](../) |
(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol |
|
|
![Cefdinir CP Impurity B](../) |
Cefdinir CP Impurity B |
|
|
![Voriconazole Impurity 15](../cas/20210111/gif/321589-00-8.gif) |
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
![Fluconazole Impurity 2](../) |
Fluconazole Impurity 2 |
|
|
![Imatinib EP Impurity D Chloride](../) |
Imatinib EP Impurity D Chloride |
|
|
![N1-Methylbenzene-1,2,4-triaMine](../cas/gif/60651-29-8.gif) |
N1-Methylbenzene-1,2,4-triaMine |
60651-29-8 |
C7H11N3 |
![RocuroniuMbroMide iMpurity H](../) |
RocuroniuMbroMide iMpurity H |
|
|
![1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid](../cas/20130318/gif/cb82611222.gif) |
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid |
1696392-11-6 |
C24H21N3O4 |
![5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan](../cas/gif/64169-45-5.gif) |
5-chloro-1-(3-diMethylaMinopropyl)-1-(4-fluorophenyl)-phthalan |
64169-45-5 |
C19H21ClFNO |
![dextroMethorphanone](../) |
dextroMethorphanone |
|
|
![oxiracetaM related substance ISF3886](../cas/20180808/gif/120428-80-0.gif) |
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
![Carvedilol IMpurity D](../cas/gif/1391052-16-6.gif) |
Carvedilol IMpurity D |
1391052-16-6 |
C39H39N3O6 |
![DL-2-(4-Carboxyphenyl)propionic Acid](../cas/gif/67381-50-4.gif) |
DL-2-(4-Carboxyphenyl)propionic Acid |
67381-50-4 |
C10H10O4 |
![Betamethasone 17-Propionate 21-Mesylate](../cas/gif/15423-80-0.gif) |
Betamethasone 17-Propionate 21-Mesylate |
15423-80-0 |
C26H35FO8S |
![ClarithroMycin EP IMpurity F](../cas/gif/128940-83-0.gif) |
ClarithroMycin EP IMpurity F |
128940-83-0 |
C39H71NO13 |
![3(R)-Hydroperoxy Simvastatin](../cas/gif/1092716-42-1.gif) |
3(R)-Hydroperoxy Simvastatin |
1092716-42-1 |
C25H38O7 |
![Albendazole EP IMpurity F](../cas/gif/80983-45-5.gif) |
Albendazole EP IMpurity F |
80983-45-5 |
C10H11N3O2S |
![10-Dehydrobaccatin V](../cas/gif/151636-94-1.gif) |
10-Dehydrobaccatin V |
151636-94-1 |
C29H34O10 |
![DoxylaMine EP IMpurity A](../cas/gif/873407-01-3.gif) |
DoxylaMine EP IMpurity A |
873407-01-3 |
C17H22N2O |
![((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane)](../cas/gif/115540-28-8.gif) |
((1R,3R,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-diMethylhept-3-en-2-yl)-7a-Methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-Methylenecyclohexane-1,3-diyl)bis(oxy)bis(tert-butyldiMethylsilane) |
115540-28-8 |
C40H72O2Si2 |
![Clopidogrel EP IMpurity D](../../https@cas/20150408/GIF/1421283-60-4.gif) |
Clopidogrel EP IMpurity D |
1421283-60-4 |
C24H21Cl2NO4S |
![Loratadine IMpurity E](../cas/20150408/gif/cb82630382.gif) |
Loratadine IMpurity E |
|
C22H23ClN2O2 |
![Metoprolol IMpurity E](../cas/20150408/gif/cb82630397.gif) |
Metoprolol IMpurity E |
|
C15H25NO3 |
![IMp. A (EP): 4-Methyl-6-(1-Methyl-1H-benziMidazol-2-yl)-2-propyl-1H-benziMidazole](../) |
IMp. A (EP): 4-Methyl-6-(1-Methyl-1H-benziMidazol-2-yl)-2-propyl-1H-benziMidazole |
|
|
![(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester](../cas/20150408/gif/401566-80-1.gif) |
(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
401566-80-1 |
C27H38N6O3S |
![4-Methoxy-5-(3-Morpholinopropoxy)-2-nitrobenzaMide](../cas/20150408/gif/861453-16-9.gif) |
4-Methoxy-5-(3-Morpholinopropoxy)-2-nitrobenzaMide |
861453-16-9 |
C15H21N3O6 |
![5-chloro-3-sulfo-2-Thiophenecarboxylic acid](../cas/20150408/gif/187746-94-7.gif) |
5-chloro-3-sulfo-2-Thiophenecarboxylic acid |
187746-94-7 |
C5H3ClO5S2 |
![2,2'-(4,4'-(3,3'-(isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl))bis(oxy)bis(4,1-phenylene))diacetaMide](../cas/gif/87619-83-8.gif) |
2,2'-(4,4'-(3,3'-(isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl))bis(oxy)bis(4,1-phenylene))diacetaMide |
87619-83-8 |
C25H35N3O6 |
![3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol](../cas/20180906/gif/177415-76-8.gif) |
3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol |
177415-76-8 |
C20H18N4O2 |
![5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](../cas/20150408/gif/1391194-39-0.gif) |
5-(2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1391194-39-0 |
C20H20FNO3S |
![(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide](../cas/20150408/gif/862894-96-0.gif) |
(S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide |
862894-96-0 |
C19H22N4O3 |
![Favipiravir Impurity](../) |
Favipiravir Impurity |
|
|
![Vildagliptin Dione Impurity](../cas/20210111/gif/1844894-70-7.gif) |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
![NA](../) |
NA |
|
|
![Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate](../cas/20210111/gif/1440961-11-4.gif) |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
![1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-](../cas/20210111/gif/2170562-55-5.gif) |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
![Apixaban Impurity 70](../cas/20211123/gif/1998079-14-3.gif) |
Apixaban Impurity 70 |
1998079-14-3 |
C44H40N8O9 |
![Favipiravir Impurity 14](../cas/20210111/gif/356783-49-8.gif) |
Favipiravir Impurity 14 |
356783-49-8 |
C5HClFN3 |
![Posaconazole Impurity 93](../cas/20200611/gif/165115-82-2.gif) |
Posaconazole Impurity 93 |
165115-82-2 |
C19H19F2IO2 |
![NA](../) |
NA |
|
|
![4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one](../) |
4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
![Ticagrelor iMpurity](../cas/20210111/gif/1882095-51-3.gif) |
Ticagrelor iMpurity |
1882095-51-3 |
C27H45N5O8S |
![cefaclor iMpurity G](../cas/20150408/gif/cb82665568.gif) |
cefaclor iMpurity G |
67308-21-8 |
C16H17N3O4S |
![Rupatadine iMpurity E](../) |
Rupatadine iMpurity E |
|
|
![Tadalafil iMpurity D](../cas/20200611/gif/951661-81-7.gif) |
Tadalafil iMpurity D |
951661-81-7 |
C22H20ClN3O4 |
![Ceftriaxone IMpurit C](../) |
Ceftriaxone IMpurit C |
|
|
![Flucloxacillin IMpurity G](../) |
Flucloxacillin IMpurity G |
|
|
![Gefitinib N-Oxide](../cas/20180808/gif/847949-51-3.gif) |
Gefitinib N-Oxide |
847949-51-3 |
C22H24ClFN4O4 |
![Milrinone IMpurity 3](../cas/20150408/gif/98293-81-3.gif) |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
![Nicardipine Related CoMpound 4](../cas/20180808/gif/123973-71-7.gif) |
Nicardipine Related CoMpound 4 |
123973-71-7 |
C25H27N3O6 |
![PraMipexole IMp.BI-II786BS](../) |
PraMipexole IMp.BI-II786BS |
|
|
![Propofol IMpurity E](../) |
Propofol IMpurity E |
|
|
![Solifenacin Related CoMpound 5](../) |
Solifenacin Related CoMpound 5 |
|
|
![TelMisartan BroMo Ethyl Ester](../cas/20180808/gif/133085-87-7.gif) |
TelMisartan BroMo Ethyl Ester |
133085-87-7 |
C16H15BrO2 |
![Tolterodine Lactol IMpurity](../cas/20180808/gif/209747-04-6.gif) |
Tolterodine Lactol IMpurity |
209747-04-6 |
C16H16O2 |
![Valsartan N1-Trityl IMpurity](../) |
Valsartan N1-Trityl IMpurity |
|
|
![(3-Carbamoylallyl)trimethylammonium](../cas/20150408/gif/857162-57-3.gif) |
(3-Carbamoylallyl)trimethylammonium |
857162-57-3 |
C7H15N2O+ |
![3-CHLORO-4-HYDROXYACETANILIDE](../cas/gif/3964-54-3.gif) |
3-CHLORO-4-HYDROXYACETANILIDE |
3964-54-3 |
C8H8ClNO2 |
![Apixaban IMpurity(BMS-591329-01)](../) |
Apixaban IMpurity(BMS-591329-01) |
|
|
![ent-14S-3-Methoxy-17-MethylMorphinan](../cas/20150408/gif/1453167-99-1.gif) |
ent-14S-3-Methoxy-17-MethylMorphinan |
1453167-99-1 |
C18H25NO |
![PD 224378](../cas/gif/501665-88-9.gif) |
PD 224378 |
501665-88-9 |
C20H35NO11 |
![(rac,syn)-4-Deschloro-sertraline](../cas/gif/871838-58-3.gif) |
(rac,syn)-4-Deschloro-sertraline |
871838-58-3 |
C17H18ClN |
![1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol](../cas/20150408/gif/93413-86-6.gif) |
1-[2-(DiMethylaMino)-1-phenylethyl]cyclohexanol |
93413-86-6 |
C16H25NO |
![1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol](../cas/20150408/gif/82961-02-2.gif) |
1-[4-(2-Methoxyethenyl)phenoxy]-3-[(1-Methylethyl)aMino]-2-propanol |
82961-02-2 |
C15H23NO3 |
![11-Desethyl Irinotecan](../cas/gif/103816-16-6.gif) |
11-Desethyl Irinotecan |
103816-16-6 |
C31H34N4O6 |
![5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide](../cas/20150408/gif/142885-92-5.gif) |
5-Methoxy-2-[[(4-Methoxy-3,5-diMethyl-2-pyridinyl)Methyl]thio]-1H-benziMidazole N-Oxide |
142885-92-5 |
C17H19N3O3S |
![1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one](../cas/20150408/gif/cb82715870.gif) |
1-((2R,3R)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one |
2243786-01-6 |
C30H35N5O3 |
![5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde](../cas/20150408/gif/cb82716549.gif) |
5-(3-fluorophenyl)-1H-pyrrole-3-carbaldehyde |
|
C11H8FNO |
![1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester](../cas/20150408/gif/21881-78-7.gif) |
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester |
21881-78-7 |
C21H26N2O6 |
![2-(4-Methylphenyl)sulfonyloxyethanol](../cas/20150408/gif/42772-85-0.gif) |
2-(4-Methylphenyl)sulfonyloxyethanol |
42772-85-0 |
C9H12O4S |
![2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)-](../cas/20200611/gif/1564265-94-6.gif) |
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-94-6 |
C18H25N3O2 |
![EMpagliflozin iMpurity 8](../) |
EMpagliflozin iMpurity 8 |
|
|
![EMpagliflozin iMpurity 13](../cas/20210111/gif/2125472-55-9.gif) |
EMpagliflozin iMpurity 13 |
2125472-55-9 |
C23H25ClO8 |
![6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole))](../cas/20180906/gif/1365727-07-6.gif) |
6-Methyldi(ondansetron-3-de(1,2-diMethyl-1H-iMidazole)) |
1365727-07-6 |
C27H26N2O2 |
![(-)-Syringaresinol-4-O-beta-D-glucopyranoside](../cas/20180808/gif/137038-13-2.gif) |
(-)-Syringaresinol-4-O-beta-D-glucopyranoside |
137038-13-2 |
C28H36O13 |
![Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione)](../cas/20210111/gif/910299-74-0.gif) |
Budesonide Impurity (1, 4-Androstadien-11-beta-16-alfa-diol-3, 17-dione) |
910299-74-0 |
C19H24O4 |
![Etoricoxib Impurity 12](../cas/20180808/gif/646459-41-8.gif) |
Etoricoxib Impurity 12 |
646459-41-8 |
C21H16ClN3O2S |
![Levofloxacin Tetrafluoro Impurity 2](../cas/20210111/gif/103995-33-1.gif) |
Levofloxacin Tetrafluoro Impurity 2 |
103995-33-1 |
C14H12F4O4 |
![Mupirocin Impurity C](../cas/20180703/gif/cb82741866.gif) |
Mupirocin Impurity C |
|
C26H44O9 |
![Verapamil Impurity H](../cas/20180703/gif/67018-83-1.gif) |
Verapamil Impurity H |
67018-83-1 |
C26H36N2O4 |
![Warfarin Impurity 1](../cas/20180703/gif/55901-61-6.gif) |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
![Vitexin -4''-O-glucoside](../cas/20180906/gif/178468-00-3.gif) |
Vitexin -4''-O-glucoside |
178468-00-3 |
C27H30O15 |
![Aripiprazole EP impurity D](../) |
Aripiprazole EP impurity D |
|
|
![Macitentan impurity B](../cas/20180808/gif/441796-13-0.gif) |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
![Meropenem IMP B](../) |
Meropenem IMP B |
|
|
![tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate](../cas/gif/412348-27-7.gif) |
tert-butyl 4-(6-bromopyridin-3-yl)piperazine-1-carboxylate |
412348-27-7 |
C14H20BrN3O2 |
![ETHYL 3,4-EPOXYBUTANOATE](../structurefile/cb8276779.gif) |
ETHYL 3,4-EPOXYBUTANOATE |
32223-97-5 |
C6H10O3 |